Hormonal suppression for endometriosis results in a reduction in bone mineral density after up to a year of treatment, with each therapy showing distinct effects, according to a meta-analysis.

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...

Novosteo Inc. will use funding to advance development of NOV004 for the treatment of bone fractures, other bone diseases and support Phase 1 clinical trials. WEST LAFAYETTE, Ind. – Novosteo Inc., a ...

A Johns Hopkins study suggests the parathyroid hormone may stop chronic back pain at its source by reversing nerve growth in ...

Bone health during breast cancer treatment can be a concern, but there are ways to reduce the impact. If a person is at risk for a loss of bone density, doctors can prescribe medications. Lifestyle ...

In patients with hormone receptor–positive early-stage breast cancer, adjuvant endocrine treatment administered for up to 5-10 years after diagnosis significantly reduces the risk of recurrence and ...

Cellular therapies that harness a patient’s own immune system to identify and eliminate cancer cells are rapidly expanding ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...